Details for: CTNNB1

Gene ID: 1499

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CTNNB1

Ensembl ID: ENSG00000168036

Description: catenin beta 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • BEST4+ enteroycte CL4030026
    CSI 48.82
    rCSI 60.72%
    PRS 17.92
  • neural crest cell CL0011012
    CSI 45.14
    rCSI 35.68%
    PRS 11.65
  • epithelial cell of lower respiratory tract CL0002632
    CSI 40.78
    rCSI 31.62%
    PRS 16.19
  • ciliated epithelial cell CL0000067
    CSI 35.75
    rCSI 31.43%
    PRS 12.3
  • intestinal epithelial cell CL0002563
    CSI 34.19
    rCSI 35.74%
    PRS 17.75
  • placental villous trophoblast CL2000060
    CSI 30.06
    rCSI 46.45%
    PRS 15.84
  • radial glial cell CL0000681
    CSI 28.74
    rCSI 39.93%
    PRS 17.4
  • small intestine goblet cell CL1000495
    CSI 28.5
    rCSI 62.42%
    PRS 22.66
  • pancreatic ductal cell CL0002079
    CSI 28.28
    rCSI 55%
    PRS 17.34
  • cerebral cortex endothelial cell CL1001602
    CSI 24.27
    rCSI 41.97%
    PRS 12.9
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 24.08
    rCSI 64.91%
    PRS 21.89
  • paneth cell of epithelium of small intestine CL1000343
    CSI 22.8
    rCSI 63.9%
    PRS 26.22
  • intermediate monocyte CL0002393
    CSI 20.86
    rCSI 31.47%
    PRS 17.01
  • colon goblet cell CL0009039
    CSI 19.45
    rCSI 46.23%
    PRS 25.36
  • lung ciliated cell CL1000271
    CSI 19.01
    rCSI 21.99%
    PRS 12.43
  • M cell of gut CL0000682
    CSI 18.44
    rCSI 19.6%
    PRS 29.45
  • sncg GABAergic cortical interneuron CL4023015
    CSI 18.18
    rCSI 29.24%
    PRS 10.83
  • endothelial cell of placenta CL0009092
    CSI 17.73
    rCSI 87.39%
    PRS 22.98
  • L6b glutamatergic cortical neuron CL4023038
    CSI 17.58
    rCSI 54.95%
    PRS 10.66
  • glioblast CL0000030
    CSI 16.85
    rCSI 26.88%
    PRS 14.56
  • stromal cell of ovary CL0002132
    CSI 16.66
    rCSI 45.77%
    PRS 27.91
  • microcirculation associated smooth muscle cell CL0008035
    CSI 15
    rCSI 43.43%
    PRS 19.21
  • enterocyte of epithelium of large intestine CL0002071
    CSI 13.76
    rCSI 72.26%
    PRS 29.32
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 13.44
    rCSI 22.57%
    PRS 9.98
  • colon epithelial cell CL0011108
    CSI 13.15
    rCSI 13.77%
    PRS 15.77
  • paneth cell CL0000510
    CSI 12.9
    rCSI 19.04%
    PRS 26.59
  • stem cell CL0000034
    CSI 12.81
    rCSI 12.36%
    PRS 12.1
  • elicited macrophage CL0000861
    CSI 12.78
    rCSI 11.73%
    PRS 19.71
  • Hofbauer cell CL3000001
    CSI 12.57
    rCSI 23.73%
    PRS 21.3
  • keratinocyte CL0000312
    CSI 11.73
    rCSI 9.83%
    PRS 20.22
  • transit amplifying cell of colon CL0009011
    CSI 11.49
    rCSI 13.5%
    PRS 19.8
  • forebrain radial glial cell CL0013000
    CSI 11.48
    rCSI 36.85%
    PRS 24.54
  • conjunctival epithelial cell CL1000432
    CSI 10.55
    rCSI 16.11%
    PRS 17.04
  • tissue-resident macrophage CL0000864
    CSI 10.41
    rCSI 48.72%
    PRS 34.23
  • transit amplifying cell of small intestine CL0009012
    CSI 10.26
    rCSI 45.04%
    PRS 31.4
  • mesodermal cell CL0000222
    CSI 10.26
    rCSI 12.31%
    PRS 16.68
  • enteroendocrine cell of small intestine CL0009006
    CSI 10.2
    rCSI 22.47%
    PRS 25.81
  • tuft cell of colon CL0009041
    CSI 9.4
    rCSI 21.91%
    PRS 34.36
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 9.16
    rCSI 16.17%
    PRS 9.95
  • enterocyte CL0000584
    CSI 8.89
    rCSI 14.33%
    PRS 26.48
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 8.8
    rCSI 11.52%
    PRS 24.01
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 8.75
    rCSI 52.91%
    PRS 37.53
  • endothelial cell of uterus CL0009095
    CSI 8.36
    rCSI 61.14%
    PRS 44.59
  • melanocyte CL0000148
    CSI 8.07
    rCSI 5.97%
    PRS 14.87
  • intestinal crypt stem cell of colon CL0009043
    CSI 7.9
    rCSI 59.32%
    PRS 30.74
  • pancreatic stellate cell CL0002410
    CSI 7.41
    rCSI 43.11%
    PRS 25.32
  • endothelial cell of arteriole CL1000412
    CSI 7.4
    rCSI 41.05%
    PRS 45.72
  • myeloid dendritic cell CL0000782
    CSI 6.65
    rCSI 9.64%
    PRS 25.32
  • type EC enteroendocrine cell CL0000577
    CSI 6.42
    rCSI 22.78%
    PRS 27.59
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 6.18
    rCSI 4.76%
    PRS 15.62
  • colon macrophage CL0009038
    CSI 5.78
    rCSI 26.68%
    PRS 35.1
  • nasal mucosa goblet cell CL0002480
    CSI 5.75
    rCSI 6.67%
    PRS 24.76
  • alveolar macrophage CL0000583
    CSI 5.73
    rCSI 9.45%
    PRS 19.98
  • enteroglial cell CL4040002
    CSI 5.73
    rCSI 30.11%
    PRS 29.35
  • epithelial cell CL0000066
    CSI 5.3
    rCSI 8.15%
    PRS 23.52
  • memory T cell CL0000813
    CSI 5.29
    rCSI 10.2%
    PRS 37.97
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 5
    rCSI 5.78%
    PRS 14.85
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 4.98
    rCSI 12.1%
    PRS 9.79
  • collagen secreting cell CL0000667
    CSI 4.54
    rCSI 26.03%
    PRS 52.48
  • endothelial cell of artery CL1000413
    CSI 4.42
    rCSI 6.48%
    PRS 65.4
  • extravillous trophoblast CL0008036
    CSI 4.31
    rCSI 5.33%
    PRS 14.84
  • Bergmann glial cell CL0000644
    CSI 4.29
    rCSI 5.87%
    PRS 16.86
  • cerebral cortex neuron CL0010012
    CSI 4.18
    rCSI 17.05%
    PRS 17.21
  • mature alpha-beta T cell CL0000791
    CSI 4.15
    rCSI 15.01%
    PRS 29.04
  • respiratory goblet cell CL0002370
    CSI 4.11
    rCSI 44.72%
    PRS 32.24
  • brush cell of tracheobronchial tree CL0002075
    CSI 4.1
    rCSI 12.18%
    PRS 24
  • Kupffer cell CL0000091
    CSI 4.09
    rCSI 9.36%
    PRS 16.43
  • basal cell of prostate epithelium CL0002341
    CSI 4
    rCSI 11.58%
    PRS 36.56
  • club cell CL0000158
    CSI 3.91
    rCSI 5.73%
    PRS 19.58
  • Mueller cell CL0000636
    CSI 3.85
    rCSI 8.78%
    PRS 14.58
  • naive B cell CL0000788
    CSI 3.7
    rCSI 3.17%
    PRS 28.34
  • parietal epithelial cell CL1000452
    CSI 3.69
    rCSI 9.87%
    PRS 14.04
  • epithelial cell of lung CL0000082
    CSI 3.64
    rCSI 3.02%
    PRS 16.02
  • interneuron CL0000099
    CSI 3.56
    rCSI 7.15%
    PRS 12.53
  • midbrain dopaminergic neuron CL2000097
    CSI 3.52
    rCSI 22.56%
    PRS 25.24
  • secretory cell CL0000151
    CSI 3.43
    rCSI 3.57%
    PRS 17.34
  • skin fibroblast CL0002620
    CSI 3.42
    rCSI 2.95%
    PRS 26.83
  • myeloid cell CL0000763
    CSI 3.28
    rCSI 13.53%
    PRS 47.24
  • mucosal invariant T cell CL0000940
    CSI 3.27
    rCSI 2.64%
    PRS 26.65
  • inhibitory interneuron CL0000498
    CSI 3.26
    rCSI 7.52%
    PRS 13.63
  • ependymal cell CL0000065
    CSI 3.22
    rCSI 6.53%
    PRS 8.11
  • enteric neuron CL0007011
    CSI 3.22
    rCSI 47.57%
    PRS 40.65
  • goblet cell CL0000160
    CSI 3.15
    rCSI 2.97%
    PRS 17.7
  • blood vessel endothelial cell CL0000071
    CSI 3.12
    rCSI 6.48%
    PRS 16.93
  • respiratory basal cell CL0002633
    CSI 3.1
    rCSI 3.21%
    PRS 19.91
  • direct pathway medium spiny neuron CL4023026
    CSI 3.05
    rCSI 73.08%
    PRS 8.22
  • keratocyte CL0002363
    CSI 3.04
    rCSI 7.3%
    PRS 25.2
  • lung endothelial cell CL1001567
    CSI 3.01
    rCSI 7.01%
    PRS 39.26
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 2.98
    rCSI 3.82%
    PRS 16.45
  • tendon cell CL0000388
    CSI 2.95
    rCSI 7.66%
    PRS 43.33
  • indirect pathway medium spiny neuron CL4023029
    CSI 2.93
    rCSI 70.64%
    PRS 9.18
  • paneth cell of colon CL0009009
    CSI 2.89
    rCSI 28.4%
    PRS 45.02
  • macrophage CL0000235
    CSI 2.85
    rCSI 5.18%
    PRS 58.71
  • precursor B cell CL0000817
    CSI 2.83
    rCSI 2.48%
    PRS 22.6
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 2.82
    rCSI 2.14%
    PRS 22.36
  • fallopian tube secretory epithelial cell CL4030006
    CSI 2.82
    rCSI 2.71%
    PRS 17.53
  • pro-B cell CL0000826
    CSI 2.79
    rCSI 2.31%
    PRS 17.14
  • alpha-beta T cell CL0000789
    CSI 2.79
    rCSI 3.26%
    PRS 22.81
  • Cajal-Retzius cell CL0000695
    CSI 2.78
    rCSI 21.75%
    PRS 35.09
  • hematopoietic precursor cell CL0008001
    CSI 2.76
    rCSI 2.84%
    PRS 27.55
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI -8.6
    rCSI -5.8%
    PRS 20.6%
  • retinal bipolar neuron CL0000748
    CSI -5.8
    rCSI -10.9%
    PRS 12.1%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI -3.1
    rCSI -3.1%
    PRS 26.6%
  • cardiac neuron CL0010022
    CSI -2.3
    rCSI -7.3%
    PRS 12.9%
  • immature B cell CL0000816
    CSI -2.2
    rCSI -1.6%
    PRS 25.1%
  • dopaminergic neuron CL0000700
    CSI -1.1
    rCSI -6.1%
    PRS 8.4%
  • mature T cell CL0002419
    CSI -0.7
    rCSI -0.5%
    PRS 24.7%
  • melanocyte of skin CL1000458
    CSI -0.6
    rCSI -0.8%
    PRS 9.5%
  • astrocyte of the cerebral cortex CL0002605
    CSI -0.3
    rCSI -0.6%
    PRS 10.5%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI -0.3
    rCSI -0.7%
    PRS 25.0%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI -0.2
    rCSI -0.4%
    PRS 33.6%
  • fibroblast of cardiac tissue CL0002548
    CSI -0.2
    rCSI -1.0%
    PRS 12.4%
  • diffuse bipolar 3a cell CL4033029
    CSI -0.1
    rCSI -0.9%
    PRS 17.0%
  • H2 horizontal cell CL0004218
    CSI -0.1
    rCSI -0.4%
    PRS 18.0%
  • GABAergic interneuron CL0011005
    CSI -0.1
    rCSI -1.2%
    PRS 12.1%
  • medium spiny neuron CL1001474
    CSI 0.0
    rCSI 0.2%
    PRS 7.3%
  • type B pancreatic cell CL0000169
    CSI 0.1
    rCSI 0.1%
    PRS 15.7%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.1
    rCSI 0.4%
    PRS 13.3%
  • hair follicular keratinocyte CL2000092
    CSI 0.1
    rCSI 1.3%
    PRS 59.9%
  • helper T cell CL0000912
    CSI 0.1
    rCSI 0.1%
    PRS 23.4%
  • follicular dendritic cell CL0000442
    CSI 0.1
    rCSI 1.4%
    PRS 67.2%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.1
    rCSI 0.3%
    PRS 59.0%
  • epithelial cell of urethra CL1000296
    CSI 0.1
    rCSI 2.4%
    PRS 49.0%
  • cytotoxic T cell CL0000910
    CSI 0.1
    rCSI 0.6%
    PRS 24.8%
  • erythroid progenitor cell CL0000038
    CSI 0.1
    rCSI 0.8%
    PRS 25.9%
  • mesangial cell CL0000650
    CSI 0.1
    rCSI 0.6%
    PRS 22.9%
  • decidual natural killer cell, human CL0002343
    CSI 0.2
    rCSI 1.7%
    PRS 73.8%
  • mature B cell CL0000785
    CSI 0.2
    rCSI 0.2%
    PRS 21.2%
  • IgG plasma cell CL0000985
    CSI 0.2
    rCSI 0.2%
    PRS 29.4%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.2
    rCSI 4.4%
    PRS 52.1%
  • T-helper 1 cell CL0000545
    CSI 0.2
    rCSI 0.3%
    PRS 42.6%
  • mesenchymal lymphangioblast CL0005021
    CSI 0.2
    rCSI 5.1%
    PRS 64.9%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 0.2
    rCSI 0.2%
    PRS 29.6%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.2
    rCSI 0.3%
    PRS 21.5%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 0.2
    rCSI 2.4%
    PRS 58.7%
  • tracheal goblet cell CL1000329
    CSI 0.2
    rCSI 0.5%
    PRS 33.2%
  • foveolar cell of stomach CL0002179
    CSI 0.2
    rCSI 0.5%
    PRS 27.1%
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 0.3
    rCSI 0.2%
    PRS 30.7%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.3
    rCSI 0.6%
    PRS 12.9%
  • T-helper 17 cell CL0000899
    CSI 0.3
    rCSI 0.2%
    PRS 30.1%
  • adipocyte CL0000136
    CSI 0.3
    rCSI 0.3%
    PRS 16.5%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 0.3
    rCSI 0.5%
    PRS 28.5%
  • Langerhans cell CL0000453
    CSI 0.3
    rCSI 0.4%
    PRS 29.8%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 0.3
    rCSI 0.5%
    PRS 14.0%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 0.3
    rCSI 0.3%
    PRS 15.2%
  • retinal ganglion cell CL0000740
    CSI 0.3
    rCSI 0.6%
    PRS 12.1%
  • eosinophil CL0000771
    CSI 0.3
    rCSI 1.9%
    PRS 42.6%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.3
    rCSI 1.6%
    PRS 40.3%
  • lung microvascular endothelial cell CL2000016
    CSI 0.3
    rCSI 5.7%
    PRS 48.8%
  • neuroplacodal cell CL0000032
    CSI 0.3
    rCSI 2.7%
    PRS 45.0%
  • respiratory epithelial cell CL0002368
    CSI 0.3
    rCSI 1.9%
    PRS 51.7%
  • ON midget ganglion cell CL4033046
    CSI 0.3
    rCSI 6.4%
    PRS 13.1%
  • GABAergic amacrine cell CL4030027
    CSI 0.3
    rCSI 1.1%
    PRS 14.6%
  • syncytiotrophoblast cell CL0000525
    CSI 0.3
    rCSI 0.9%
    PRS 32.1%
  • mammary gland epithelial cell CL0002327
    CSI 0.3
    rCSI 1.2%
    PRS 30.0%
  • odontoblast CL0000060
    CSI 0.3
    rCSI 7.5%
    PRS 62.4%
  • lung goblet cell CL1000143
    CSI 0.3
    rCSI 3.7%
    PRS 51.4%
  • ON parasol ganglion cell CL4033052
    CSI 0.3
    rCSI 4.8%
    PRS 12.3%
  • retinal cone cell CL0000573
    CSI 0.3
    rCSI 0.5%
    PRS 13.0%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 0.4
    rCSI 0.4%
    PRS 24.3%
  • vasa recta descending limb cell CL1001285
    CSI 0.4
    rCSI 2.8%
    PRS 60.0%
  • cholangiocyte CL1000488
    CSI 0.4
    rCSI 2.1%
    PRS 27.7%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.4
    rCSI 4.0%
    PRS 58.8%
  • retina horizontal cell CL0000745
    CSI 0.4
    rCSI 0.6%
    PRS 15.7%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.4
    rCSI 1.9%
    PRS 33.0%
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 0.4
    rCSI 0.8%
    PRS 10.7%
  • serous secreting cell of bronchus submucosal gland CL4033005
    CSI 0.4
    rCSI 2.1%
    PRS 55.1%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.4
    rCSI 0.9%
    PRS 26.9%
  • endothelial cell of venule CL1000414
    CSI 0.4
    rCSI 3.5%
    PRS 57.5%
  • pancreatic A cell CL0000171
    CSI 0.4
    rCSI 0.4%
    PRS 18.1%
  • osteoblast CL0000062
    CSI 0.4
    rCSI 10.1%
    PRS 79.7%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 0.4
    rCSI 0.6%
    PRS 15.8%
  • cell of skeletal muscle CL0000188
    CSI 0.4
    rCSI 4.6%
    PRS 69.4%
  • neural progenitor cell CL0011020
    CSI 0.4
    rCSI 1.9%
    PRS 16.2%
  • mucus secreting cell CL0000319
    CSI 0.4
    rCSI 0.7%
    PRS 21.9%
  • alternatively activated macrophage CL0000890
    CSI 0.4
    rCSI 0.6%
    PRS 26.1%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 0.4
    rCSI 0.4%
    PRS 19.0%
  • pancreatic acinar cell CL0002064
    CSI 0.5
    rCSI 0.6%
    PRS 18.5%
  • pancreatic PP cell CL0002275
    CSI 0.5
    rCSI 1.9%
    PRS 29.4%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.5
    rCSI 3.3%
    PRS 48.3%
  • skeletal muscle satellite cell CL0000594
    CSI 0.5
    rCSI 1.4%
    PRS 49.8%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.5
    rCSI 1.5%
    PRS 17.8%
  • hepatocyte CL0000182
    CSI 0.5
    rCSI 0.9%
    PRS 15.7%
  • interstitial cell of Cajal CL0002088
    CSI 0.5
    rCSI 0.6%
    PRS 19.7%
  • pancreatic epsilon cell CL0005019
    CSI 0.5
    rCSI 2.3%
    PRS 38.6%
  • squamous epithelial cell CL0000076
    CSI 0.5
    rCSI 1.2%
    PRS 21.0%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 0.5
    rCSI 0.9%
    PRS 22.4%
  • luminal cell of prostate epithelium CL0002340
    CSI 0.5
    rCSI 2.8%
    PRS 30.1%
  • intestinal tuft cell CL0019032
    CSI 0.5
    rCSI 0.8%
    PRS 19.4%
  • vasa recta ascending limb cell CL1001131
    CSI 0.5
    rCSI 2.4%
    PRS 53.8%
  • brain vascular cell CL4023072
    CSI 0.6
    rCSI 5.8%
    PRS 18.7%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 0.6
    rCSI 3.5%
    PRS 42.2%
  • suprabasal keratinocyte CL4033013
    CSI 0.6
    rCSI 0.9%
    PRS 9.9%
  • innate lymphoid cell CL0001065
    CSI 0.6
    rCSI 1.2%
    PRS 25.4%
  • neuroendocrine cell CL0000165
    CSI 0.6
    rCSI 2.2%
    PRS 33.7%
  • renal interstitial pericyte CL1001318
    CSI 0.6
    rCSI 1.6%
    PRS 15.7%
  • lung neuroendocrine cell CL1000223
    CSI 0.6
    rCSI 0.9%
    PRS 19.4%
  • dendritic cell, human CL0001056
    CSI 0.6
    rCSI 0.9%
    PRS 20.1%
  • type L enteroendocrine cell CL0002279
    CSI 0.6
    rCSI 1.1%
    PRS 33.1%
  • large pre-B-II cell CL0000957
    CSI 0.6
    rCSI 1.8%
    PRS 29.2%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CTNNB1](/details-gene/1499) encodes catenin beta-1, a crucial multifunctional protein with dual roles in cell-cell adhesion and gene transcription. As a key component of the adherens junction complex, it links cadherins to the actin cytoskeleton, thereby mediating cellular adhesion and maintaining tissue integrity. Concurrently, it serves as the central effector of the canonical Wnt signaling pathway, translocating to the nucleus to act as a transcriptional coactivator for TCF/LEF family transcription factors. Reflecting these functions, the **Overall** expression profile shows that [CTNNB1](/details-gene/1499) is highly significant in a wide array of epithelial cell types, particularly in the intestine and respiratory tract, as well as in developmental cell populations like [neural crest cell](/details-cell/CL0011012). Its widespread involvement in developmental processes and cell fate determination is underscored by its association with multiple developmental disorders and cancers, including pilomatricoma ([114550](https://omim.org/entry/114550)) and colorectal cancer ([116806](https://omim.org/entry/116806)). ## Cellular Roles and Expression Landscape The expression landscape of [CTNNB1](/details-gene/1499) highlights its fundamental role in establishing and maintaining epithelial tissues and guiding developmental processes. **Overall**, the gene shows the highest significance in cells that form barrier tissues and are involved in secretion and absorption, such as [BEST4+ enteroycte](/details-cell/CL4030026), [epithelial cell of lower respiratory tract](/details-cell/CL0002632), and [intestinal epithelial cell](/details-cell/CL0002563). Its prominence in progenitor and stem cell populations, including [neural crest cell](/details-cell/CL0011012), [radial glial cell](/details-cell/CL0000681), and [intestinal crypt stem cell of small intestine](/details-cell/CL0009017), is consistent with its function as a primary mediator of Wnt signaling, a pathway essential for self-renewal and differentiation. In stark contrast, [CTNNB1](/details-gene/1499) demonstrates low to negligible significance in several terminally differentiated cell types. This includes a broad range of mature immune cells, such as [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907) and [immature B cell](/details-cell/CL0000816), as well as various neuronal subtypes like [retinal bipolar neuron](/details-cell/CL0000748) and [dopaminergic neuron](/details-cell/CL0000700). This pattern suggests that while [CTNNB1](/details-gene/1499) is critical for the development and structural organization of tissues, its role may be substantially diminished in the specialized effector functions of mature hematopoietic and neural lineages. ## Pathways and Molecular Function The functional annotations for [CTNNB1](/details-gene/1499) confirm its dual, pivotal roles in cellular biology. Its function in cell-cell adhesion is extensively documented through its localization to the [Adherens junction](/details-cell/GO:0005912) and its direct involvement in [Adherens junctions interactions](/details-pathway/R-HSA-418990) and [Cadherin binding](/details-go/GO:0045296). This structural role is critical for the integrity of epithelial sheets, a function consistent with its high expression in cell types like [pancreatic ductal cell](/details-cell/CL0002079) and [ciliated epithelial cell](/details-cell/CL0000067). Simultaneously, [CTNNB1](/details-gene/1499) is the core component of the [Canonical wnt signaling pathway](/details-go/GO:0060070), as detailed in Reactome pathways such as [Signaling by wnt](/details-pathway/R-HSA-195721) and [Formation of the beta-catenin:tcf transactivating complex](/details-pathway/R-HSA-201722). In this capacity, it functions as a [Transcription coactivator activity](/details-go/GO:0003713). This signaling function is essential for a vast number of developmental processes, including [Gastrulation](/details-pathway/R-HSA-9758941), [Kidney development](/details-pathway/R-HSA-9830369), and [T cell differentiation in thymus](/details-go/GO:0033077). The gene's activity positively regulates cell proliferation ([GO:0008284](https://www.ebi.ac.uk/QuickGO/term/GO:0008284)) and differentiation ([GO:0045597](https://www.ebi.ac.uk/QuickGO/term/GO:0045597)), while also playing a complex role in apoptosis ([R-HSA-109581](https://reactome.org/content/detail/R-HSA-109581)). This multifaceted involvement explains its high significance in a wide range of developmental and homeostatic contexts. ## Research Directions The dual functionality of [CTNNB1](/details-gene/1499) presents unique research questions regarding the context-dependent regulation of its adhesive versus signaling roles. Its expression pattern, high in progenitors and low in terminally differentiated cells, suggests a tightly controlled regulatory switch. **Proposed Hypotheses:** 1. **Hypothesis 1:** In intestinal epithelium, the subcellular localization of the beta-catenin protein pool is the primary determinant of its function. Under homeostatic conditions, the majority of beta-catenin is sequestered at the plasma membrane in [Adherens junction](/details-cell/GO:0005912)s to maintain barrier integrity. Upon Wnt stimulation in the crypt base, a distinct, newly synthesized or released pool of beta-catenin translocates to the nucleus of [intestinal crypt stem cell of small intestine](/details-cell/CL0009017) to drive a proliferative and self-renewal transcriptional program without compromising adhesion in the surrounding cells. 2. **Hypothesis 2:** The observed downregulation of [CTNNB1](/details-gene/1499) in mature lymphocytes, such as [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907), is a necessary event for terminal differentiation and the acquisition of effector function. Persistent high-level expression of [CTNNB1](/details-gene/1499) in mature T cells would maintain a less-differentiated, stem-like state, thereby impairing their cytotoxic or helper capabilities. **Experimental Approach for Hypothesis 1:** To investigate the differential roles of beta-catenin in the intestinal epithelium, a powerful approach would be to utilize human intestinal organoids. Using CRISPR-Cas9, one could introduce a fluorescent tag (e.g., GFP) onto the endogenous [CTNNB1](/details-gene/1499) locus to visualize its localization in real-time. By stimulating these organoids with Wnt pathway agonists (e.g., R-spondin, Wnt3a) or inhibitors (e.g., IWP-2), one could use live-cell confocal microscopy to track the dynamics of beta-catenin's movement from the membrane to the nucleus in specific cell types within the crypt-villus axis. Furthermore, proximity-ligation assays (PLA) could be employed to quantify the interaction of beta-catenin with either E-cadherin (adhesion) or TCF4 (transcription) in different cellular compartments under varying conditions. This would directly test whether distinct pools of the protein are allocated to different functions based on signaling inputs. **Therapeutic Potential:** [CTNNB1](/details-gene/1499) is a well-established oncogene, with activating mutations being a primary driver in numerous cancers, including colorectal, liver, and endocrine tumors. Consequently, it represents a high-priority therapeutic target. The therapeutic strategy would focus on **inhibition**, aiming to block the transcriptional activity of the nuclear beta-catenin/TCF complex. The primary challenge is the protein's essential role in normal tissue homeostasis, particularly in the intestine. Therefore, successful therapies are likely to be those that can selectively target the oncogenic signaling complex, disrupt the interaction between beta-catenin and its nuclear binding partners, or promote the degradation of the stabilized, oncogenic form of beta-catenin while sparing its adhesive function at the cell membrane.

Genular Protein ID: 3260015589

Symbol: CTNB1_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 7806582

Title: E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.

PubMed ID: 7806582

DOI: 10.1083/jcb.127.6.2061

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16641997

Title: The DNA sequence, annotation and analysis of human chromosome 3.

PubMed ID: 16641997

DOI: 10.1038/nature04728

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12019147

Title: Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.

PubMed ID: 12019147

PubMed ID: 7982500

Title: Distinct cadherin-catenin complexes in Ca(2+)-dependent cell-cell adhesion.

PubMed ID: 7982500

DOI: 10.1016/0014-5793(94)01205-9

PubMed ID: 9020842

Title: Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations.

PubMed ID: 9020842

DOI: 10.1038/ng0297-170

PubMed ID: 10029085

Title: Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.

PubMed ID: 10029085

PubMed ID: 10187801

Title: Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration.

PubMed ID: 10187801

DOI: 10.1074/jbc.274.15.10173

PubMed ID: 10725230

Title: ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120(ctn) in E-cadherin complexes.

PubMed ID: 10725230

DOI: 10.1242/jcs.113.8.1481

PubMed ID: 10966653

Title: Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.

PubMed ID: 10966653

DOI: 10.1038/79039

PubMed ID: 11703283

Title: Beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.

PubMed ID: 11703283

DOI: 10.1046/j.1365-2133.2001.04455.x

PubMed ID: 11751639

Title: Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.

PubMed ID: 11751639

DOI: 10.1101/gad.946501

PubMed ID: 11279024

Title: Regulation of beta-catenin structure and activity by tyrosine phosphorylation.

PubMed ID: 11279024

DOI: 10.1074/jbc.m100194200

PubMed ID: 15003504

Title: CD43 has a functional NLS, interacts with beta-catenin, and affects gene expression.

PubMed ID: 15003504

DOI: 10.1016/j.bbrc.2004.02.011

PubMed ID: 21118991

Title: The EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin.

PubMed ID: 21118991

DOI: 10.1091/mbc.e10-05-0440

PubMed ID: 27226643

Title:

PubMed ID: 27226643

DOI: 10.1074/jbc.a116.100194

PubMed ID: 11590244

Title: AlphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion.

PubMed ID: 11590244

DOI: 10.1242/jcs.114.17.3177

PubMed ID: 11389839

Title: Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

PubMed ID: 11389839

DOI: 10.1016/s1097-2765(01)00242-8

PubMed ID: 11389840

Title: Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.

PubMed ID: 11389840

DOI: 10.1016/s1097-2765(01)00241-6

PubMed ID: 11464291

Title: Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

PubMed ID: 11464291

DOI: 10.1038/sj.onc.1204557

PubMed ID: 12501215

Title: Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin.

PubMed ID: 12501215

DOI: 10.1021/bi026095u

PubMed ID: 12051714

Title: Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.

PubMed ID: 12051714

DOI: 10.1016/s0006-291x(02)00485-0

PubMed ID: 12297051

Title: Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.

PubMed ID: 12297051

DOI: 10.1016/s0092-8674(02)00912-1

PubMed ID: 12027456

Title: Identification of two novel regulated serines in the N-terminus of beta-catenin.

PubMed ID: 12027456

DOI: 10.1006/excr.2002.5520

PubMed ID: 11790773

Title: Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling.

PubMed ID: 11790773

DOI: 10.1074/jbc.m108765200

PubMed ID: 11834740

Title: Wnt signaling controls the phosphorylation status of beta-catenin.

PubMed ID: 11834740

DOI: 10.1074/jbc.m111635200

PubMed ID: 12077367

Title: Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.

PubMed ID: 12077367

DOI: 10.1242/jcs.115.13.2771

PubMed ID: 12370829

Title: The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn).

PubMed ID: 12370829

DOI: 10.1038/sj.onc.1205858

PubMed ID: 12420223

Title: The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.

PubMed ID: 12420223

DOI: 10.1038/sj.onc.1205991

PubMed ID: 12830000

Title: EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.

PubMed ID: 12830000

DOI: 10.1053/jhep.2003.50270

PubMed ID: 10679188

Title: Regulation of beta-catenin signaling in the Wnt pathway.

PubMed ID: 10679188

DOI: 10.1006/bbrc.1999.1860

PubMed ID: 12640114

Title: p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

PubMed ID: 12640114

DOI: 10.1128/mcb.23.7.2287-2297.2003

PubMed ID: 12712206

Title: Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.

PubMed ID: 12712206

DOI: 10.1038/nature01570

PubMed ID: 14595118

Title: Novel membrane protein shrew-1 targets to cadherin-mediated junctions in polarized epithelial cells.

PubMed ID: 14595118

DOI: 10.1091/mbc.e03-05-0281

PubMed ID: 16424001

Title: TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby.

PubMed ID: 16424001

DOI: 10.1158/0008-5472.can-05-3124

PubMed ID: 17047063

Title: E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasion.

PubMed ID: 17047063

DOI: 10.1158/0008-5472.can-05-3096

PubMed ID: 17081983

Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

PubMed ID: 17081983

DOI: 10.1016/j.cell.2006.09.026

PubMed ID: 16858403

Title: The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus.

PubMed ID: 16858403

DOI: 10.1038/sj.emboj.7601230

PubMed ID: 17524503

Title: MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.

PubMed ID: 17524503

DOI: 10.1016/j.bbamcr.2007.04.009

PubMed ID: 17289029

Title: The Kruppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway.

PubMed ID: 17289029

DOI: 10.1016/j.febslet.2007.01.058

PubMed ID: 17009320

Title: cdk5 modulates beta- and delta-catenin/Pin1 interactions in neuronal cells.

PubMed ID: 17009320

DOI: 10.1002/jcb.21041

PubMed ID: 18077326

Title: The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.

PubMed ID: 18077326

DOI: 10.1073/pnas.0703664105

PubMed ID: 18086858

Title: beta-Catenin is a Nek2 substrate involved in centrosome separation.

PubMed ID: 18086858

DOI: 10.1101/gad.1596308

PubMed ID: 18220336

Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.

PubMed ID: 18220336

DOI: 10.1021/pr0705441

PubMed ID: 18819930

Title: Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.

PubMed ID: 18819930

DOI: 10.1158/1541-7786.mcr-07-2175

PubMed ID: 18378692

Title: CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes.

PubMed ID: 18378692

DOI: 10.1128/mcb.00322-08

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19816403

Title: The kinase TNIK is an essential activator of Wnt target genes.

PubMed ID: 19816403

DOI: 10.1038/emboj.2009.285

PubMed ID: 18957423

Title: Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells.

PubMed ID: 18957423

DOI: 10.1074/jbc.m805612200

PubMed ID: 19433865

Title: Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.

PubMed ID: 19433865

DOI: 10.1074/jbc.m109.007237

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20307497

Title: Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.

PubMed ID: 20307497

DOI: 10.1016/j.bbrc.2010.03.099

PubMed ID: 20164195

Title: The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5.

PubMed ID: 20164195

DOI: 10.1074/jbc.m109.068304

PubMed ID: 19996314

Title: Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-beta-catenin interaction.

PubMed ID: 19996314

DOI: 10.1074/jbc.m109.060301

PubMed ID: 19693690

Title: Characterization of a novel human CDK5 splicing variant that inhibits Wnt/beta-catenin signaling.

PubMed ID: 19693690

DOI: 10.1007/s11033-009-9752-7

PubMed ID: 20026641

Title: Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.

PubMed ID: 20026641

DOI: 10.1242/jcs.053264

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21262353

Title: Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and regulates insulin internalization.

PubMed ID: 21262353

DOI: 10.1016/j.cellsig.2011.01.019

PubMed ID: 21132015

Title: Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling.

PubMed ID: 21132015

DOI: 10.1038/embor.2010.185

PubMed ID: 21247902

Title: Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor.

PubMed ID: 21247902

DOI: 10.1074/jbc.m110.170803

PubMed ID: 22056988

Title: Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation.

PubMed ID: 22056988

DOI: 10.1038/nature10598

PubMed ID: 21623382

Title: Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome.

PubMed ID: 21623382

DOI: 10.1038/nm.2380

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22647378

Title: The tumor suppressor HINT1 regulates MITF and beta-catenin transcriptional activity in melanoma cells.

PubMed ID: 22647378

DOI: 10.4161/cc.20765

PubMed ID: 22699938

Title: Kindlin 2 forms a transcriptional complex with beta-catenin and TCF4 to enhance Wnt signalling.

PubMed ID: 22699938

DOI: 10.1038/embor.2012.88

PubMed ID: 22155184

Title: Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.

PubMed ID: 22155184

DOI: 10.1053/j.gastro.2011.11.041

PubMed ID: 23033978

Title: Diagnostic exome sequencing in persons with severe intellectual disability.

PubMed ID: 23033978

DOI: 10.1056/nejmoa1206524

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 25183871

Title: Simplet/Fam53b is required for Wnt signal transduction by regulating beta-catenin nuclear localization.

PubMed ID: 25183871

DOI: 10.1242/dev.108415

PubMed ID: 24342833

Title: beta-catenin is O-GlcNAc glycosylated at Serine 23: implications for beta-catenin's subcellular localization and transactivator function.

PubMed ID: 24342833

DOI: 10.1016/j.yexcr.2013.11.021

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25266658

Title: The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of beta-catenin.

PubMed ID: 25266658

DOI: 10.1128/mcb.00731-14

PubMed ID: 24824780

Title: MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.

PubMed ID: 24824780

DOI: 10.1002/ijc.28967

PubMed ID: 25169422

Title: HN1 negatively influences the beta-catenin/E-cadherin interaction, and contributes to migration in prostate cells.

PubMed ID: 25169422

DOI: 10.1002/jcb.24956

PubMed ID: 25807484

Title: Loss of delta-catenin function in severe autism.

PubMed ID: 25807484

DOI: 10.1038/nature14186

PubMed ID: 28829046

Title: Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis.

PubMed ID: 28829046

DOI: 10.1038/cr.2017.107

PubMed ID: 28051089

Title: Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation.

PubMed ID: 28051089

DOI: 10.1038/mi.2016.120

PubMed ID: 29432739

Title: KSHV vPK inhibits Wnt signaling via preventing interactions between beta-catenin and TCF4.

PubMed ID: 29432739

DOI: 10.1016/j.bbrc.2018.02.089

PubMed ID: 29367600

Title: Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/beta-catenin pathway.

PubMed ID: 29367600

DOI: 10.1038/s41419-017-0128-y

PubMed ID: 28575650

Title: Defects in the cell signaling mediator beta-catenin cause the retinal vascular condition FEVR.

PubMed ID: 28575650

DOI: 10.1016/j.ajhg.2017.05.001

PubMed ID: 29374064

Title: Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-beta-Catenin Signaling Axis.

PubMed ID: 29374064

DOI: 10.1158/0008-5472.can-17-2403

PubMed ID: 29739711

Title: SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling via Transcriptional and Posttranslational Regulation of beta-Catenin in Lung Cancer.

PubMed ID: 29739711

DOI: 10.1016/j.ebiom.2018.04.026

PubMed ID: 30097457

Title: FLYWCH1, a Novel Suppressor of Nuclear beta-Catenin, Regulates Migration and Morphology in Colorectal Cancer.

PubMed ID: 30097457

DOI: 10.1158/1541-7786.mcr-18-0262

PubMed ID: 31073040

Title: LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling.

PubMed ID: 31073040

DOI: 10.1126/science.aau0812

PubMed ID: 31801859

Title: beta-Catenin Is Required for the cGAS/STING Signaling Pathway but Antagonized by the Herpes Simplex Virus 1 US3 Protein.

PubMed ID: 31801859

DOI: 10.1128/jvi.01847-19

PubMed ID: 11136974

Title: Crystal structure of a beta-catenin/Tcf complex.

PubMed ID: 11136974

DOI: 10.1016/s0092-8674(00)00192-6

PubMed ID: 11713475

Title: Tcf4 can specifically recognize beta-catenin using alternative conformations.

PubMed ID: 11713475

DOI: 10.1038/nsb718

PubMed ID: 11713476

Title: Structure of a human Tcf4-beta-catenin complex.

PubMed ID: 11713476

DOI: 10.1038/nsb720

PubMed ID: 12408824

Title: The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT.

PubMed ID: 12408824

DOI: 10.1016/s1097-2765(02)00637-8

PubMed ID: 17052462

Title: Crystal structure of a beta-catenin/BCL9/Tcf4 complex.

PubMed ID: 17052462

DOI: 10.1016/j.molcel.2006.09.001

PubMed ID: 9065402

Title: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

PubMed ID: 9065402

DOI: 10.1126/science.275.5307.1787

PubMed ID: 9927029

Title: Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.

PubMed ID: 9927029

PubMed ID: 10398436

Title: Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.

PubMed ID: 10398436

DOI: 10.1002/(sici)1098-2264(199908)25:4<399::aid-gcc14>3.3.co;2-o

PubMed ID: 10391090

Title: Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas.

PubMed ID: 10391090

DOI: 10.1111/j.1349-7006.1999.tb00777.x

PubMed ID: 10655994

Title: A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.

PubMed ID: 10655994

DOI: 10.1136/jcp.52.9.695

PubMed ID: 10192393

Title: A common human skin tumour is caused by activating mutations in beta-catenin.

PubMed ID: 10192393

DOI: 10.1038/7747

PubMed ID: 10435629

Title: Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

PubMed ID: 10435629

DOI: 10.1038/sj.onc.1202800

PubMed ID: 10666372

Title: APC mutations in sporadic medulloblastomas.

PubMed ID: 10666372

DOI: 10.1016/s0002-9440(10)64747-5

PubMed ID: 25326669

Title: De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.

PubMed ID: 25326669

DOI: 10.1007/s00439-014-1498-1

PubMed ID: 28514307

Title: Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.

PubMed ID: 28514307

DOI: 10.1097/md.0000000000006914

PubMed ID: 38173341

Title: A mosaic variant in CTNNB1/beta-catenin as a novel cause for osteopathia striata with cranial sclerosis.

PubMed ID: 38173341

DOI: 10.1210/clinem/dgad757

Sequence Information:

  • Length: 781
  • Mass: 85497
  • Checksum: CB78F165A3EEF86E
  • Sequence:
  • MATQADLMEL DMAMEPDRKA AVSHWQQQSY LDSGIHSGAT TTAPSLSGKG NPEEEDVDTS 
    QVLYEWEQGF SQSFTQEQVA DIDGQYAMTR AQRVRAAMFP ETLDEGMQIP STQFDAAHPT 
    NVQRLAEPSQ MLKHAVVNLI NYQDDAELAT RAIPELTKLL NDEDQVVVNK AAVMVHQLSK 
    KEASRHAIMR SPQMVSAIVR TMQNTNDVET ARCTAGTLHN LSHHREGLLA IFKSGGIPAL 
    VKMLGSPVDS VLFYAITTLH NLLLHQEGAK MAVRLAGGLQ KMVALLNKTN VKFLAITTDC 
    LQILAYGNQE SKLIILASGG PQALVNIMRT YTYEKLLWTT SRVLKVLSVC SSNKPAIVEA 
    GGMQALGLHL TDPSQRLVQN CLWTLRNLSD AATKQEGMEG LLGTLVQLLG SDDINVVTCA 
    AGILSNLTCN NYKNKMMVCQ VGGIEALVRT VLRAGDREDI TEPAICALRH LTSRHQEAEM 
    AQNAVRLHYG LPVVVKLLHP PSHWPLIKAT VGLIRNLALC PANHAPLREQ GAIPRLVQLL 
    VRAHQDTQRR TSMGGTQQQF VEGVRMEEIV EGCTGALHIL ARDVHNRIVI RGLNTIPLFV 
    QLLYSPIENI QRVAAGVLCE LAQDKEAAEA IEAEGATAPL TELLHSRNEG VATYAAAVLF 
    RMSEDKPQDY KKRLSVELTS SLFRTEPMAW NETADLGLDI GAQGEPLGYR QDDPSYRSFH 
    SGGYGQDALG MDPMMEHEMG GHHPGADYPV DGLPDLGHAQ DLMDGLPPGD SNQLAWFDTD 
    L

Genular Protein ID: 1188022148

Symbol: B4DGU4_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 17081983

Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

PubMed ID: 17081983

DOI: 10.1016/j.cell.2006.09.026

PubMed ID: 16641997

Title: The DNA sequence, annotation and analysis of human chromosome 3.

PubMed ID: 16641997

DOI: 10.1038/nature04728

PubMed ID: 18220336

Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.

PubMed ID: 18220336

DOI: 10.1021/pr0705441

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

Sequence Information:

  • Length: 774
  • Mass: 84766
  • Checksum: 785874CCE2EC6DC2
  • Sequence:
  • MELDMAMEPD RKAAVSHWQQ QSYLDSGIHS GATTTAPSLS GKGNPEEEDV DTSQVLYEWE 
    QGFSQSFTQE QVADIDGQYA MTRAQRVRAA MFPETLDEGM QIPSTQFDAA HPTNVQRLAE 
    PSQMLKHAVV NLINYQDDAE LATRAIPELT KLLNDEDQVV VNKAAVMVHQ LSKKEASRHA 
    IMRSPQMVSA IVRTMQNTND VETARCTAGT LHNLSHHREG LLAIFKSGGI PALVKMLGSP 
    VDSVLFYAIT TLHNLLLHQE GAKMAVRLAG GLQKMVALLN KTNVKFLAIT TDCLQILAYG 
    NQESKLIILA SGGPQALVNI MRTYTYEKLL WTTSRVLKVL SVCSSNKPAI VEAGGMQALG 
    LHLTDPSQRL VQNCLWTLRN LSDAATKQEG MEGLLGTLVQ LLGSDDINVV TCAAGILSNL 
    TCNNYKNKMM VCQVGGIEAL VRTVLRAGDR EDITEPAICA LRHLTSRHQE AEMAQNAVRL 
    HYGLPVVVKL LHPPSHWPLI KATVGLIRNL ALCPANHAPL REQGAIPRLV QLLVRAHQDT 
    QRRTSMGGTQ QQFVEGVRME EIVEGCTGAL HILARDVHNR IVIRGLNTIP LFVQLLYSPI 
    ENIQRVAAGV LCELAQDKEA AEAIEAEGAT APLTELLHSR NEGVATYAAA VLFRMSEDKP 
    QDYKKRLSVE LTSSLFRTEP MAWNETADLG LDIGAQGEPL GYRQDDPSYR SFHSGGYGQD 
    ALGMDPMMEH EMGGHHPGAD YPVDGLPDLG HAQDLMDGLP PGDSNQLAWF DTDL